Published in J Immunol on May 15, 1993
Altered T cell development in mice with a targeted mutation of the CD3-epsilon gene. EMBO J (1995) 2.84
Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes. J Exp Med (1999) 2.81
Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity (2013) 2.69
Maintenance of T cell specification and differentiation requires recurrent notch receptor-ligand interactions. J Exp Med (2004) 2.58
The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development. Genes Dev (2000) 2.49
Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice. EMBO J (2000) 2.41
Non-redundant role for the transcription factor Gli1 at multiple stages of thymocyte development. Cell Cycle (2010) 2.32
Immunosenescence: emerging challenges for an ageing population. Immunology (2007) 2.32
RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells. Immunity (1998) 2.15
Epigenetic characterization of hematopoietic stem cell differentiation using miniChIP and bisulfite sequencing analysis. Proc Natl Acad Sci U S A (2007) 2.13
International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev (2013) 2.11
Identification of novel lymphoid tissues in murine intestinal mucosa where clusters of c-kit+ IL-7R+ Thy1+ lympho-hemopoietic progenitors develop. J Exp Med (1996) 2.06
Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus. J Exp Med (2001) 2.02
The transcriptional repressor Gfi1 affects development of early, uncommitted c-Kit+ T cell progenitors and CD4/CD8 lineage decision in the thymus. J Exp Med (2003) 1.96
The bHLH gene Hes1 is essential for expansion of early T cell precursors. Genes Dev (1999) 1.95
Thymic dendritic cell precursors: relationship to the T lymphocyte lineage and phenotype of the dendritic cell progeny. J Exp Med (1996) 1.94
Prdm16 is a physiologic regulator of hematopoietic stem cells. Blood (2011) 1.86
Pre-T cell receptor (TCR) and TCR-controlled checkpoints in T cell differentiation are set by Ikaros. J Exp Med (1999) 1.82
Survivin loss in thymocytes triggers p53-mediated growth arrest and p53-independent cell death. J Exp Med (2004) 1.80
GPR30 contributes to estrogen-induced thymic atrophy. Mol Endocrinol (2007) 1.78
Complementation in trans of altered thymocyte development in mice expressing mutant forms of the adaptor molecule SLP76. Immunity (2008) 1.72
A multipotent precursor in the thymus maps to the branching point of the T versus B lineage decision. J Exp Med (2005) 1.72
Functions of E2A-HEB heterodimers in T-cell development revealed by a dominant negative mutation of HEB. Mol Cell Biol (2000) 1.70
c-Myb is essential for early T cell development. Genes Dev (1999) 1.70
Notch ligands Delta 1 and Jagged1 transmit distinct signals to T-cell precursors. Blood (2004) 1.68
The transcriptional landscape of αβ T cell differentiation. Nat Immunol (2013) 1.61
Impairment of T cell development in deltaEF1 mutant mice. J Exp Med (1997) 1.56
Impairment of T and B cell development by treatment with a type I interferon. J Exp Med (1998) 1.54
Thymic T-cell development in allogeneic stem cell transplantation. Blood (2011) 1.53
IL-7 receptor signals inhibit expression of transcription factors TCF-1, LEF-1, and RORgammat: impact on thymocyte development. J Exp Med (2004) 1.52
Two waves of recombinase gene expression in developing thymocytes. J Exp Med (1994) 1.52
Id3 restricts the developmental potential of gamma delta lineage during thymopoiesis. J Immunol (2009) 1.49
Lineage infidelity in myeloid cells with TCR gene rearrangement: a latent developmental potential of proT cells revealed by ectopic cytokine receptor signaling. Proc Natl Acad Sci U S A (2002) 1.49
Thymic T cell development and progenitor localization depend on CCR7. J Exp Med (2004) 1.48
Identification of a bone marrow precursor of the earliest thymocytes in adult mouse. Proc Natl Acad Sci U S A (2007) 1.47
Abnormal T cell development in CD3-zeta-/- mutant mice and identification of a novel T cell population in the intestine. EMBO J (1993) 1.46
The BCL2A1 gene as a pre-T cell receptor-induced regulator of thymocyte survival. J Exp Med (2005) 1.46
Thymic development beyond beta-selection requires phosphatidylinositol 3-kinase activation by CXCR4. J Exp Med (2009) 1.46
Identification of the earliest natural killer cell-committed progenitor in murine bone marrow. Blood (2011) 1.45
A dynamic assembly of diverse transcription factors integrates activation and cell-type information for interleukin 2 gene regulation. Proc Natl Acad Sci U S A (1996) 1.42
Haemopedia: An Expression Atlas of Murine Hematopoietic Cells. Stem Cell Reports (2016) 1.39
Kinetics of T cell receptor beta, gamma, and delta rearrangements during adult thymic development: T cell receptor rearrangements are present in CD44(+)CD25(+) Pro-T thymocytes. Proc Natl Acad Sci U S A (1998) 1.37
Thymic involution in aging. J Clin Immunol (2000) 1.37
Critical roles of the PI3K/Akt signaling pathway in T cell development. Immunol Lett (2008) 1.37
Positive and negative regulation of V(D)J recombination by the E2A proteins. J Exp Med (1999) 1.36
E2A and HEB are required to block thymocyte proliferation prior to pre-TCR expression. J Immunol (2007) 1.36
The earliest thymic T cell progenitors sustain B cell and myeloid lineage potential. Nat Immunol (2012) 1.35
Ikaros induces quiescence and T-cell differentiation in a leukemia cell line. Mol Cell Biol (2005) 1.33
Primitive lymphoid progenitors in bone marrow with T lineage reconstituting potential. J Immunol (2006) 1.33
The CD3gamma chain is essential for development of both the TCRalphabeta and TCRgammadelta lineages. EMBO J (1998) 1.33
Evidence implicating Gfi-1 and Pim-1 in pre-T-cell differentiation steps associated with beta-selection. EMBO J (1998) 1.32
The stream of precursors that colonizes the thymus proceeds selectively through the early T lineage precursor stage of T cell development. J Exp Med (2008) 1.31
Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells. J Exp Med (1996) 1.30
The effect of in vivo IL-7 deprivation on T cell maturation. J Exp Med (1995) 1.30
Stat5 synergizes with T cell receptor/antigen stimulation in the development of lymphoblastic lymphoma. J Exp Med (2003) 1.29
Temporal and lineage-specific control of T cell receptor alpha/delta gene rearrangement by T cell receptor alpha and delta enhancers. J Exp Med (1994) 1.26
Distinct roles of prostaglandin H synthases 1 and 2 in T-cell development. J Clin Invest (1999) 1.25
Fine-scale staging of T cell lineage commitment in adult mouse thymus. J Immunol (2010) 1.25
TOX provides a link between calcineurin activation and CD8 lineage commitment. J Exp Med (2004) 1.24
BAC-mediated transgenic expression of fluorescent autophagic protein Beclin 1 reveals a role for Beclin 1 in lymphocyte development. Cell Death Differ (2008) 1.23
Identification of a novel developmental stage marking lineage commitment of progenitor thymocytes. J Exp Med (1997) 1.21
Differential role of SLP-76 domains in T cell development and function. Proc Natl Acad Sci U S A (2002) 1.20
The common cytokine receptor gamma chain and the pre-T cell receptor provide independent but critically overlapping signals in early alpha/beta T cell development. J Exp Med (1999) 1.19
Multiple prethymic defects underlie age-related loss of T progenitor competence. Blood (2007) 1.19
Role of different T cell receptors in the development of pre-T cells. J Exp Med (1997) 1.18
IL-7Ralpha and E47: independent pathways required for development of multipotent lymphoid progenitors. EMBO J (2002) 1.17
Lin-Sca1+kit- bone marrow cells contain early lymphoid-committed precursors that are distinct from common lymphoid progenitors. J Immunol (2008) 1.14
T-cell lineage determination. Immunol Rev (2010) 1.14
Enforced expression of EBF in hematopoietic stem cells restricts lymphopoiesis to the B cell lineage. EMBO J (2003) 1.13
Human intrathymic lineage commitment is marked by differential CD7 expression: identification of CD7- lympho-myeloid thymic progenitors. Blood (2007) 1.12
Developmental dissociation of thymic dendritic cell and thymocyte lineages revealed in growth factor receptor mutant mice. Proc Natl Acad Sci U S A (1999) 1.08
Unexpected role for the B cell-specific Src family kinase B lymphoid kinase in the development of IL-17-producing γδ T cells. J Immunol (2010) 1.06
c-Myb promotes the survival of CD4+CD8+ double-positive thymocytes through upregulation of Bcl-xL. J Immunol (2010) 1.05
Identification of the mouse killer immunoglobulin-like receptor-like (Kirl) gene family mapping to chromosome X. Immunogenetics (2003) 1.03
An alternate pathway for T cell development supported by the bone marrow microenvironment: recapitulation of thymic maturation. J Exp Med (1998) 1.01
Interleukin 7 induces preferential expansion of V beta 8.2+CD4-8- and V beta 8.2+CD4+8- murine thymocytes positively selected by class I molecules. J Exp Med (1994) 1.00
WASp verprolin homology, cofilin homology, and acidic region domain-mediated actin polymerization is required for T cell development. Proc Natl Acad Sci U S A (2002) 0.99
Intrathymic expression of Flt3 ligand enhances thymic recovery after irradiation. J Exp Med (2008) 0.99
Thymic function is maintained during Salmonella-induced atrophy and recovery. J Immunol (2012) 0.98
E2a/Pbx1 induces the rapid proliferation of stem cell factor-dependent murine pro-T cells that cause acute T-lymphoid or myeloid leukemias in mice. Mol Cell Biol (2004) 0.98
Proliferation kinetics associated with T cell receptor-beta chain selection of fetal murine thymocytes. J Exp Med (1996) 0.97
Identification of an early T cell progenitor for a pathway of T cell maturation in the bone marrow. Proc Natl Acad Sci U S A (1999) 0.97
Intrathymic IL-7: the where, when, and why of IL-7 signaling during T cell development. Semin Immunol (2012) 0.97
VEGF-mediated cross-talk within the neonatal murine thymus. Blood (2008) 0.97
The thymus chapter in the life of gut-specific intra epithelial lymphocytes. Curr Opin Immunol (2008) 0.96
TLX1/HOX11-mediated disruption of primary thymocyte differentiation prior to the CD4+CD8+ double-positive stage. Br J Haematol (2006) 0.96
Two distinct pathways of positive selection for thymocytes. Proc Natl Acad Sci U S A (1998) 0.96
Human alpha beta and gamma delta thymocyte development: TCR gene rearrangements, intracellular TCR beta expression, and gamma delta developmental potential--differences between men and mice. J Immunol (2006) 0.95
An alternative NFAT-activation pathway mediated by IL-7 is critical for early thymocyte development. Nat Immunol (2012) 0.95
Developmental regulation of VDJ recombination by the core fragment of the T cell receptor alpha enhancer. J Exp Med (1997) 0.95
Shb deficient mice display an augmented TH2 response in peripheral CD4+ T cells. BMC Immunol (2011) 0.94
The immunopathology of thymic GVHD. Semin Immunopathol (2008) 0.94
Polysialic acid governs T-cell development by regulating progenitor access to the thymus. Proc Natl Acad Sci U S A (2009) 0.94
Signal-transducing adaptor molecules STAM1 and STAM2 are required for T-cell development and survival. Mol Cell Biol (2002) 0.93
Life and death in the thymus--cell death signaling during T cell development. Curr Opin Cell Biol (2010) 0.93
Id1 attenuates Notch signaling and impairs T-cell commitment by elevating Deltex1 expression. Mol Cell Biol (2009) 0.92
Interferons alpha/beta inhibit IL-7-induced proliferation of CD4- CD8- CD3- CD44+ CD25+ thymocytes, but do not inhibit that of CD4- CD8- CD3- CD44- CD25- thymocytes. Immunology (1997) 0.91
The biological activity of natural and mutant pTalpha alleles. J Exp Med (2001) 0.90
Interleukin-7 inhibits pre-T-cell differentiation induced by the pre-T-cell receptor signal and the effect is mimicked by hGM-CSF in hGM-CSF receptor transgenic mice. Immunology (2002) 0.89
Block of T lymphocyte differentiation by activation of the cAMP-dependent signal transduction pathway. EMBO J (1996) 0.89
Involvement of chemokine receptors in breast cancer metastasis. Nature (2001) 26.07
IL-10 inhibits cytokine production by activated macrophages. J Immunol (1991) 13.13
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A (1998) 12.61
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol (1991) 11.04
The biology of chemokines and their receptors. Annu Rev Immunol (2000) 9.81
Lethal effect of the anti-Fas antibody in mice. Nature (1993) 9.20
A new class of membrane-bound chemokine with a CX3C motif. Nature (1997) 7.87
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest (1999) 7.66
Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell (1994) 7.23
B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. J Immunol (1986) 6.16
Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med (1998) 6.12
Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol (1994) 5.93
Chemokines and the arrest of lymphocytes rolling under flow conditions. Science (1998) 5.34
STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther (2008) 5.17
Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med (2000) 5.02
Fas and Fas ligand: lpr and gld mutations. Immunol Today (1995) 4.69
Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci U S A (1990) 4.40
Osteoblastic cells are involved in osteoclast formation. Endocrinology (1988) 4.37
Interleukin-induced increase in Ia expression by normal mouse B cells. J Exp Med (1984) 4.14
Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A (1981) 4.12
Multiple dopamine D4 receptor variants in the human population. Nature (1992) 4.08
The major histocompatibility complex-restricted antigen receptor on T cells. II. Role of the L3T4 product. J Exp Med (1983) 3.54
Control points in early T-cell development. Immunol Today (1993) 3.33
A role for hematopoietic stem cells in promoting angiogenesis. Cell (2000) 3.25
In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells. Blood (1992) 3.15
Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med (1999) 3.07
Essential roles of the Fas ligand in the development of hepatitis. Nat Med (1997) 3.05
IL-10, a novel growth cofactor for mature and immature T cells. J Immunol (1990) 3.02
CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci U S A (1999) 3.00
Expression of the functional soluble form of human fas ligand in activated lymphocytes. EMBO J (1995) 2.87
Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res (1996) 2.86
Biological activity of 25-hydroxyergocalciferol in rats. J Nutr (1970) 2.85
The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology (1989) 2.83
Lymphotactin: a cytokine that represents a new class of chemokine. Science (1994) 2.74
Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol (1994) 2.74
Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med (1988) 2.71
Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev (2000) 2.68
Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol (2000) 2.66
6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7. J Cell Biol (1998) 2.62
Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology (1988) 2.60
Post-traumatic stress disorder. Br J Psychiatry (1989) 2.57
Fas ligand in human serum. Nat Med (1996) 2.53
Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science (1997) 2.52
Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest (1993) 2.52
Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. Biochemistry (1971) 2.50
Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand. Nat Med (1998) 2.47
Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis. Immunity (1998) 2.46
Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J Clin Invest (1999) 2.43
A survey to identify the clinical coding and classification systems currently in use across Europe. Stud Health Technol Inform (2001) 2.41
Onset of TCR-beta gene rearrangement and role of TCR-beta expression during CD3-CD4-CD8- thymocyte differentiation. J Immunol (1994) 2.38
Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med (2000) 2.38
IL-10: a novel cytotoxic T cell differentiation factor. J Immunol (1991) 2.32
The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J Immunol (1998) 2.32
Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology (2007) 2.32
Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J Exp Med (1991) 2.31
Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3alpha and MIP-3beta. J Immunol (1997) 2.30
Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat (2011) 2.30
Disparate differentiation in mouse hemopoietic colonies derived from paired progenitors. Proc Natl Acad Sci U S A (1984) 2.29
CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J Exp Med (1997) 2.24
Enzymic and substrate basis for the anaplerotic step in guard cells. Plant Physiol (1978) 2.24
Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. Cancer Res (1996) 2.22
1 alpha,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun (1981) 2.21
Detection of hypoglycemia with the GlucoWatch biographer. Diabetes Care (2001) 2.20
Peritonitis due to a mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis. J Infect Dis (1982) 2.20
Simulated home delivery in hospital: a randomised controlled trial. Br J Obstet Gynaecol (1993) 2.16
Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol (1991) 2.16
The reduced expression of 6Ckine in the plt mouse results from the deletion of one of two 6Ckine genes. J Exp Med (1999) 2.14
IL-7 is a growth and maintenance factor for mature and immature thymocyte subsets. Int Immunol (1989) 2.10
The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology (2000) 2.08
Scapulothoracic motion in normal shoulders and shoulders with glenohumeral instability and impingement syndrome. A study using Moiré topographic analysis. Clin Orthop Relat Res (1992) 2.07
Aberrant in vivo T helper type 2 cell response and impaired eosinophil recruitment in CC chemokine receptor 8 knockout mice. J Exp Med (2001) 2.07
Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp Cell Res (1999) 2.06
Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule. Blood (1991) 2.02
TECK: a novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development. Immunity (1997) 1.98
Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. J Clin Invest (2000) 1.98
Production of the antitumor drug epirubicin (4'-epidoxorubicin) and its precursor by a genetically engineered strain of Streptomyces peucetius. Nat Biotechnol (1998) 1.97
Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J Immunol (1999) 1.96
Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol (2000) 1.95
Deficiency of osteoclasts in osteopetrotic mice is due to a defect in the local microenvironment provided by osteoblastic cells. Endocrinology (1991) 1.90
The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun (1990) 1.88
Permissive role of interleukin 3 (IL-3) in proliferation and differentiation of multipotential hemopoietic progenitors in culture. J Cell Physiol (1985) 1.87
Role of gamma-interferon in antibody-producing responses. Nature (1984) 1.87
Identification and characterization of a novel beta chemokine containing six conserved cysteines. J Immunol (1997) 1.87
Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2). J Biol Chem (2000) 1.86
Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum (2001) 1.85
Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor gamma chain. Blood (1996) 1.85
Molecular biology of interleukin 4 and interleukin 5 genes and biology of their products that stimulate B cells, T cells and hemopoietic cells. Immunol Rev (1988) 1.84
Patterns of flexibility, laxity, and strength in normal shoulders and shoulders with instability and impingement. Am J Sports Med (1990) 1.83
Tumor necrosis factor alpha/cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines. J Exp Med (1988) 1.82
Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer. Int J Cancer (1999) 1.81
Cytokine production by mature and immature CD4-CD8- T cells. Alpha beta-T cell receptor+ CD4-CD8- T cells produce IL-4. J Immunol (1992) 1.80
Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J Clin Invest (1997) 1.79
Voluntary, named testing for HIV in a community based antenatal clinic: a pilot study. BMJ (1995) 1.78
Biological activity of 1,25-dihydroxycholecalciferol. Biochemistry (1971) 1.77
Correlation between 25-hydroxyvitamin D3 1 alpha-hydroxylase gene expression in alveolar macrophages and the activity of sarcoidosis. Am J Med (2001) 1.77
IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J Immunol (1990) 1.77